Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|March 12, 2014
Anti-angiogenic therapy, a new player in the field of sarcoma treatmentYvonne M H Versleijen-Jonkers, Myrella Vlenterie, Addy C M van de Luijtgaarden, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Clinical applications of positron emission tomography in sarcoma managementElske Quak, Addy C M van de Luijtgaarden, Lioe-Fee de Geus-Oei, et al.
European Urology Open Science|March 2, 2026
Discrepancies Between Global Consensus and Local Implementation in the Management of Advanced Prostate CancerNiven Mehra, Daniela E Oprea-Lager, Addy C M van de Luijtgaarden, et al.
Virchows Archiv : an International Journal of Pathology|October 20, 2009
Metastatic potential of an aneurysmal bone cystAddy C M van de Luijtgaarden, Rene P H Veth, Piet J Slootweg, et al.
Future Oncology (London, England)|October 26, 2013
IGF signaling pathway analysis of osteosarcomas reveals the prognostic value of pAKT localizationAddy C M van de Luijtgaarden, Melissa H S Roeffen, Manon A Leus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507Emmy D G Fleuren, Yvonne M H Versleijen-Jonkers, Addy C M van de Luijtgaarden, et al.
International Journal of Cancer|October 16, 2025
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocolIlse A C Spiekman, Niven Mehra, Laurien J Zeverijn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer PatientsDianne Bosch, Kim J M van der Velden, Irma M Oving, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2022
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapyMaarten J van der Doelen, Irma M Oving, Dirk N J Wyndaele, et al.
Clinical Genitourinary Cancer|December 30, 2019
Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the NetherlandsMalou C P Kuppen, Hans M Westgeest, Alphonsus J M van den Eertwegh, et al.
Pageof 2